PACDB provides the information on pathogens (e.g. bacteria, fungus, toxin and virus) adhering to carbohydrates expressed on the cell surface of host animals or plants.
Database | Last Updated |
---|---|
Pathogen Adherence to Carbohydrate Database (PACDB) | June 1, 2016 |
Species | Pathogen Adherence Molecule | Ligand Name | Ligand Feature | Target Source | Glycan Sequence ▲ | Binding | PubMed ID |
---|---|---|---|---|---|---|---|
Unknown
|
I-active Gal2-lactoisooctaosylceramide
|
Oligoglycosylceramides
|
Human colon adenocarcinoma cells (WiDr )
|
Gal(a1-3)Gal(b1-4)GlcNAc(b1-6)[Gal(a1-3)Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
Unknown
|
I-active Sialyl lactoisooctaosylceramide
|
Sialoglycosphingolipids
|
Human colon adenocarcinoma cells (WiDr )
|
Gal(a1-3)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
Neutrophil-activating proteins (150-kDa)
|
I-active Sialyl lactoisooctaosylceramide
|
Sialoglycosphingolipids
|
Bovine erythrocytes
|
Gal(a1-3)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
Unknown
|
I-active Sialyl lactoisooctaosylceramide
|
Sialoglycosphingolipids
|
Gal(a1-3)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
|||
Unknown
|
Blood group B antigen
|
Oligosaccharides
|
Saliva
|
Gal(a1-3)[Fuc(a1-2)]Gal
|
Binding
|
||
Unknown
|
Blood group B antigen
|
Oligosaccharides
|
Human saliva
|
Gal(a1-3)[Fuc(a1-2)]Gal
|
Not Binding
|
||
Unknown
|
Blood group B antigen
|
Oligosaccharides
|
Saliva
|
Gal(a1-3)[Fuc(a1-2)]Gal
|
Not Binding
|
||
PA-IIL
|
Blood group B antigen
|
Oligosaccharides
|
Gal(a1-3)[Fuc(a1-2)]Gal
|
Binding
|
|||
RSL (30-kDa proteins)
|
Blood group B antigen
|
Oligosaccharides
|
Gal(a1-3)[Fuc(a1-2)]Gal
|
Binding
|
|||
Capsid proteins
|
Blood group B antigen
|
Oligosaccharides
|
Gal(a1-3)[Fuc(a1-2)]Gal
|
Binding
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01